incretina glp 1 Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic Dr.Syed - GLP-1 & GIP

The main drawback of pentavalent antimonials is their severe toxicity, including cardiotoxicity (e.g., ventricular tachycardia, prolonged QTc interval), pancreatitis, pancytopenia, and nephrotoxicity

[DOI] [PubMed] [Google Scholar] Meister A

These molecules are designed to be membrane-permeable, meaning they can cross cell membranes and access their target enzyme inside cells

These medications work by activating GLP-1 receptors, helping people feel fuller longer, eat less, and lose weight

S., Mandave, P

The board authorized the new buyback to be executed over three years, following the complete utilization of a prior $100 million program launched in July 2024